RBC Europe’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
RBC Europe's IDXX Position: Q2 2022 in Review
RBC Europe increased its Idexx Laboratories (IDXX) stake by 8.8% in Q2 2022, buying an estimated $129K and bringing the position to 3,916 shares worth $1.37M. The position accounts for 0.07% of the portfolio, ranked #94.
RBC Europe first reported a position in IDXX in Q3 2017 and has held it in 20 quarters since. The position peaked at $3.32M in Q3 2021. 957 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.
- RBC Europe held 3,916 shares of Idexx Laboratories worth $1.37M as of Q2 2022.
- RBC Europe bought 316 Idexx Laboratories shares in Q2 2022, an estimated $129K.
- Idexx Laboratories made up 0.07% of RBC Europe's portfolio in Q2 2022, its #94 holding.
- RBC Europe first reported a position in Idexx Laboratories in Q3 2017 and has held it in 20 quarters since.
- RBC Europe's Idexx Laboratories position peaked at $3.32M in Q3 2021.
- 957 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.
Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.